Albanol B
Based on 1 Customer Validation
Albanol B is an arylbenzofuran derivative which can be isolated from mulberries. Albanol B exhibits anti-Alzheimer's disease, anti-bacterial and antioxidant activities. Albanol B inhibits cancer cells proliferation, down-regulates CDK1 expression. Albanol B also induces cell cycle arrest at G2/M and apoptosis. And Albanol B induces mitochondrial ROS production and increases the phosphorylation levels of AKT and ERK1/2.
For research use only. We do not sell to patients.
- Purity: 99.79%
- CAS No.: 87084-99-9
- Formula: C34H22O8
- Molecular Weight:558.53
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Albanol B (10 μM, 30 μM; 24 h) decreases cell viability of A549 cells[1].
Albanol B (30 μM; 48 h) arrrests cell cycle at G2/M phase and induces apoptosis in A549 and H1975 cells[1].
Albanol B (1-30 μM; 1-9 h) mediates the activation of ERK-1/2 and AKT in A549 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549 cells, BZR, NCI-H1975, and NCI-H226 cells
-
Concentration:0, 1, 3, 10, and 30 μM
-
Incubation Time:48 hours
-
Result:Exhibited inhibitory effects on cancer cells with IC50s of 5.6 μM (A549), 8.9 μM (BZR), 12.7 μM (NCI-H1975), and 15 μM (NCI-H226), respectively.
-
Cell Line:A549 and H1975 cells
-
Concentration:1, 3, 10 μM
-
Incubation Time:48 hours
-
Result:Increased cells in G2/M phase from 9.5% to 14.34%, 18.13% and 47.9%, respectively.
-
Cell Line:A549 cells
-
Concentration:1 h, 3 h, 6 h, and 9 h
-
Incubation Time:48 hours
-
Result:Increased the phosphorylation levels of ERK1/2 and AKT in time- and concentration-dependent manners.
Did not increase the phosphorylation level of JNK and p38 MAPKs.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:EX-3LL tumor-bearing mice[1]
-
Dosage:50 mg/kg, 100 mg/kg
-
Administration:IP; once daily for 21 days
-
Result:Decreased tumor volume and weight by 48.0% and 41.0% (for 50 mg/kg treatment), and 61.3% and 57.3% (for 100 mg/kg treatment), respectively.
Chemical Information
-
CAS No. 87084-99-9
-
Appearance Solid
-
Molecular Weight 558.53
-
Formula C34H22O8
-
Color Off-white to gray
-
SMILES
OC1=C(C=CC(O)=C1)[C@@]23C4=C(C5=CC=C(O)C=C5O3)C=C(C)C=C4C6=C(O)C=C(C(OC7=C8)=CC7=CC=C8O)C=C6O2
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Albanol B Related Classifications
HY-N11439 Related Classifications
Powered by Bioz